FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805018982> ?p ?o ?g. }

• W2805018982 abstract "Objective:The problem of drug interactions is increasingly important today because they may induce serious adverse events as well as interfere with efficacy of pharmacotherapy. Combinations of drugs are most often prescribed to patients presenting with comorbid pathology. The incidence of a combination of arterial hypertension (AH) and acid-dependent diseases (ADDs) varies widely ranging from 11.6 to 50%. One of combinations of drugs prescribed to such patients is a combination of calcium channel blocker amlodipine and proton pump inhibitor omeprazole. The latter in the human body undergoes biotransformation mediated at the level of cytochrome P450 by isoenzymes CYP2C19 and CYP3A4. Amlodipine is a substrate of the isoenzyme CYP3A4, which increases the probability of the development of interaction between these drugs. The purpose of our study was to investigate antihypertensive efficacy of amlodipine in patients suffering from arterial hypertension combined with acid-dependent diseases and additionally taking omeprazole.Method:Study included a total of 150 patients with AH and ADD. Antihypertensive therapy was evaluated by means of office measuring of arterial pressure (AP) and circadian monitoring of AP (CMAP). The followed-up patients with AH and ADD were divided into 2 groups. Group One was composed of hypertensive patients undergoing pharmacotherapy with 10 mg amlodipine, whose condition required due to exacerbation of ADD administration of omeprazole at a dose of 20 mg for a period from 3 to 4 weeks. Group Two comprised hypertensive patients receiving antihypertensive therapy consisting of 10 mg amlodipine, who were found to have remission of acid-dependent diseases, with no additional medication taken.Results:The obtained findings demonstrated that one of the commonly used drug combinations in treatment of patients with AH and ADD in ambulatory conditions was a combination of omeprazole and amlodipine, accounting for 7.1%. The results of office measurement of arterial pressure (AP) 2 weeks after initiating pharmacotherapy with omeprazole in patients with AH and ADD demonstrated that the patients receiving omeprazole in addition to antihypertensive therapy were found to have a statistically significant decrease in systolic arterial pressure (SAP) and statistically significantly more pronounced dynamics of a decrease in diastolic arterial pressure (SAP) (p<0.05) compared with those not receiving therapy with omeprazole. Also, in the group of patients taking omeprazole, the findings of circadian monitoring of blood pressure (CMAP) showed a statistically significant decrease in average circadian SAP, average circadian DAP, mean value of daytime SAP and mean value of nighttime SAP (p<0.05).Conclusion:The obtained findings demonstrated that simultaneous prescription of amlodipine and omeprazole to patients with concomitant pathology, i.e., AH and ADD, turned out to enhance the antihypertensive affect of amlodipine, which probably resulted from substrate competition of amlodipine and omeprazole at the level isoenzyme CYP 3A4 of cytochrome P450." @default.
• W2805018982 created "2018-06-01" @default.
• W2805018982 creator A5007207543 @default.
• W2805018982 creator A5023634612 @default.
• W2805018982 creator A5052324453 @default.
• W2805018982 creator A5057252978 @default.
• W2805018982 creator A5091799283 @default.
• W2805018982 date "2018-05-27" @default.
• W2805018982 modified "2023-09-26" @default.
• W2805018982 title "Effect of omeprazole on antihypertensive efficacy of amlodipine in patients with comorbid pathology – arterial hypertension and acid-dependent disease" @default.
• W2805018982 doi "https://doi.org/10.29333/ejgm/91723" @default.
• W2805018982 hasPublicationYear "2018" @default.
• W2805018982 type Work @default.
• W2805018982 sameAs 2805018982 @default.
• W2805018982 citedByCount "0" @default.
• W2805018982 crossrefType "journal-article" @default.
• W2805018982 hasAuthorship W2805018982A5007207543 @default.
• W2805018982 hasAuthorship W2805018982A5023634612 @default.
• W2805018982 hasAuthorship W2805018982A5052324453 @default.
• W2805018982 hasAuthorship W2805018982A5057252978 @default.
• W2805018982 hasAuthorship W2805018982A5091799283 @default.
• W2805018982 hasBestOaLocation W28050189821 @default.
• W2805018982 hasConcept C109650736 @default.
• W2805018982 hasConcept C126322002 @default.
• W2805018982 hasConcept C140840227 @default.
• W2805018982 hasConcept C164705383 @default.
• W2805018982 hasConcept C197934379 @default.
• W2805018982 hasConcept C2777014857 @default.
• W2805018982 hasConcept C2777498785 @default.
• W2805018982 hasConcept C2779646130 @default.
• W2805018982 hasConcept C2781025758 @default.
• W2805018982 hasConcept C500440147 @default.
• W2805018982 hasConcept C526171541 @default.
• W2805018982 hasConcept C62231903 @default.
• W2805018982 hasConcept C71924100 @default.
• W2805018982 hasConcept C84393581 @default.
• W2805018982 hasConcept C90924648 @default.
• W2805018982 hasConcept C98274493 @default.
• W2805018982 hasConceptScore W2805018982C109650736 @default.
• W2805018982 hasConceptScore W2805018982C126322002 @default.
• W2805018982 hasConceptScore W2805018982C140840227 @default.
• W2805018982 hasConceptScore W2805018982C164705383 @default.
• W2805018982 hasConceptScore W2805018982C197934379 @default.
• W2805018982 hasConceptScore W2805018982C2777014857 @default.
• W2805018982 hasConceptScore W2805018982C2777498785 @default.
• W2805018982 hasConceptScore W2805018982C2779646130 @default.
• W2805018982 hasConceptScore W2805018982C2781025758 @default.
• W2805018982 hasConceptScore W2805018982C500440147 @default.
• W2805018982 hasConceptScore W2805018982C526171541 @default.
• W2805018982 hasConceptScore W2805018982C62231903 @default.
• W2805018982 hasConceptScore W2805018982C71924100 @default.
• W2805018982 hasConceptScore W2805018982C84393581 @default.
• W2805018982 hasConceptScore W2805018982C90924648 @default.
• W2805018982 hasConceptScore W2805018982C98274493 @default.
• W2805018982 hasLocation W28050189821 @default.
• W2805018982 hasOpenAccess W2805018982 @default.
• W2805018982 hasPrimaryLocation W28050189821 @default.
• W2805018982 hasRelatedWork W1795719079 @default.
• W2805018982 hasRelatedWork W2001951727 @default.
• W2805018982 hasRelatedWork W2015329819 @default.
• W2805018982 hasRelatedWork W2038421254 @default.
• W2805018982 hasRelatedWork W2073774399 @default.
• W2805018982 hasRelatedWork W2094925677 @default.
• W2805018982 hasRelatedWork W2237078136 @default.
• W2805018982 hasRelatedWork W2360096642 @default.
• W2805018982 hasRelatedWork W2366584333 @default.
• W2805018982 hasRelatedWork W2368268745 @default.
• W2805018982 hasRelatedWork W2374474172 @default.
• W2805018982 hasRelatedWork W2394469040 @default.
• W2805018982 hasRelatedWork W2413900349 @default.
• W2805018982 hasRelatedWork W2552124019 @default.
• W2805018982 hasRelatedWork W2608370482 @default.
• W2805018982 hasRelatedWork W2746448871 @default.
• W2805018982 hasRelatedWork W2972629583 @default.
• W2805018982 hasRelatedWork W3114873941 @default.
• W2805018982 hasRelatedWork W759864740 @default.
• W2805018982 hasRelatedWork W90976518 @default.
• W2805018982 isParatext "false" @default.
• W2805018982 isRetracted "false" @default.
• W2805018982 magId "2805018982" @default.
• W2805018982 workType "article" @default.